{
    "nctId": "NCT03729115",
    "briefTitle": "A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer",
    "officialTitle": "Chicago Alternative Prevention Study for Diverse Populations of High Risk Women",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 400,
    "primaryOutcomeMeasure": "Development of faster MRI protocols for a for a Personalized Risk-based Imaging Surveillance Model for diverse populations of high risk women.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n- Known BRCA1 or BRCA2, TP53, PALB2, PTEN, CDH1 and STK11 carrier. Women with pathogenic mutations in any other cancer susceptibility genes are eligible only if they also have a high PRS.\n\nOR\n\n* With life time risk of 30% or higher, based on Polygenic Risk Score that integrates genetic and non-genetic factors OR\n* 5-years risk \u2265 6% for women 40-64 OR\n* 5-years risk \u2265 6% for women 65+ AND breast density C or D AND a lifetime risk \\>= 20% (BCSC+PRS LTR or Tyrer-Cuzick LTR) OR\n* Patients with history of chest wall radiation received before age 35. OR\n* To promote health equity, women of African Ancestry \\< 45 years with at least one 1st or 2nd degree relative with breast or ovarian cancer are eligible because PRS Scores are not currently reported for AA women.\n* Must be at least 25 years old.\n* Willing to travel to participating site for imaging studies as well as any necessary follow-up procedures.\n* Be able to give informed consent.\n\n  * Patients with prior history of breast or ovarian cancer are eligible if they have completed all active treatments and are cancer free for two years.\n\nExclusion Criteria\n\n* Undergoing active cancer treatment at the time of enrollment.\n* Current pregnancy or plans for pregnancy within two years of enrollment.\n* Presence of a pacemaker or any other metallic foreign object in their body that interferes with an MRI.\n* Breast surgery within two weeks of study entry.\n* Women with history of bilateral mastectomy are not eligible\n* History of kidney disease or abnormal kidney function.\n* History of dye allergy unless it can be mediated with antihistamines and/or steroids\n\n  * Women can be taking hormone replacement therapy, tamoxifen, raloxifene, aromatase inhibitors, Parp Inhibitors as adjuvant therapy or participating in a chemoprevention trial.",
    "sex": "FEMALE",
    "minimumAge": "25 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}